DEF: GoHealth Seeks Stockholder Approval for Amended Incentive Plan and Director Elections at 2025 Annual Meeting

GoHealth is holding its annual stockholder meeting on June 18, 2025, to vote on director elections, ratify the accounting firm, approve executive compensation, and amend the 2020 Incentive Award Plan.

Summary

• GoHealth, Inc. is holding its 2025 Annual Meeting of Stockholders virtually on June 18, 2025.
• Stockholders will vote on the election of three Class II Directors: Brandon M. Cruz, Alan Wheatley, and Abhiraj R. Modi.
• They will also vote to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• An advisory vote will be held to approve the compensation of the company's Named Executive Officers.
• Stockholders will also vote on approving an amendment to the company's 2020 Incentive Award Plan to increase the number of shares available for issuance by 225,000 shares.
• The board of directors recommends voting FOR all proposals.
• As of the record date, April 21, 2025, there were 50,000 shares of Series A Preferred Stock, 11,083,440 shares of Class A common stock, and 12,623,288 shares of Class B common stock outstanding and entitled to vote.
• The Series A Preferred Stock were convertible into 5,810,853 shares of Class A common stock however, the voting interests of the two holders of Series A Preferred Stock is capped at 9.99% and 4.99% pursuant to the Certificate of Designation.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The positive aspects include the company's commitment to corporate governance and the alignment of employee and stockholder interests. The negative aspects include the company's controlled company status and related party transactions.

Positives

• The board of directors is actively engaged in corporate governance, with established committees and guidelines.
• The company is seeking stockholder approval for an amendment to the 2020 Incentive Award Plan, which aims to align employee and stockholder interests.
• The company is providing detailed information about the nominees for Class II Director positions.
• The company is seeking to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm, demonstrating a commitment to sound financial oversight.

Negatives

• The company is a controlled company, which means it is exempt from certain corporate governance standards.
• The company has had related party transactions, including lease agreements with entities controlled by the Founders.
• The company has a Tax Receivable Agreement, which could result in significant payments to Continuing Equity Owners and Blocker Shareholders.
• The company's directors may be removed only for cause by the affirmative vote of the holders of at least two-thirds of our outstanding voting stock entitled to vote in the election of directors.

Risks

• The division of the Board of Directors into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company.
• The Stockholders Agreement gives Centerbridge and NVX Holdings significant control over the election of directors.
• The company is a controlled company, which means it is exempt from certain corporate governance standards.
• The company has had related party transactions, including lease agreements with entities controlled by the Founders.
• The company has a Tax Receivable Agreement, which could result in significant payments to Continuing Equity Owners and Blocker Shareholders.

Future Outlook

The company is seeking to increase the number of Class A Shares available under the 2020 Plan by 225,000 Class A Shares, with 218,551 shares of the increase intended to be granted to Mr. Kotte pursuant to the terms of his amended employment agreement.

Industry Context

This announcement is typical for publicly traded companies as they prepare for their annual stockholder meetings, addressing standard governance matters such as director elections, auditor ratification, and executive compensation.

Comparison to Industry Standards

• The structure of GoHealth's board and compensation practices appear consistent with other publicly traded companies, particularly those with significant private equity ownership.
• The use of staggered board terms and stockholder agreements is a common mechanism for maintaining control.
• The executive compensation structure, including base salary, bonus, and equity awards, aligns with general industry practices.
• The related party transactions, particularly the lease agreements, are disclosed as required but warrant scrutiny to ensure they are on market terms.

Management Changes

Corporate Governance

Related Party Transactions

• The company has entered into various lease agreements with entities controlled by the Founders.
• Anthem Insurance Companies, Inc., an owner of our Series A Preferred Stock, is a wholly-owned subsidiary of Elevance Health, Inc. (Elevance). Elevance is the owner of health plan partners with which we enter into contractual agency relationships.
• On July 15, 2020, we entered into a Tax Receivable Agreement with GoHealth Holdings, LLC, Continuing Equity Owners and the Blocker Shareholders that provides for the payment by GoHealth, Inc. to the Continuing Equity Owners and the Blocker Shareholders of 85% of the amount of certain tax benefits, if any, that GoHealth, Inc. actually realizes, or in some circumstances is deemed to realize as a result of the transactions described above, including the acquisition of GoHealth, Inc.s allocable share of the existing tax basis in GoHealth Holdings, LLCs assets in connection with the Transactions (including the Blocker Companys share of existing tax basis), increases to such allocable share of existing tax basis, the Basis Adjustments and certain other tax benefits arising from payments made under the Tax Receivable Agreement.

Stakeholder Impact

• Stockholders are being asked to vote on key governance matters, including director elections and executive compensation.
• Employees may be affected by the proposed amendment to the 2020 Incentive Award Plan.
• The company's financial performance and strategic decisions could impact stakeholders such as customers, suppliers, and creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on June 18, 2025.
• The company will report the final results of the Annual Meeting in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Stockholders, Incentive Award Plan, Director Election, Executive Compensation, Ernst & Young, Corporate Governance, GoHealth